Our mission is to help everyone lead the healthiest lives that science and medicine allow
At Color, we believe everyone should be able to benefit from affordable, convenient, and high-quality healthcare. For the last decade, our team has been on a journey to remove barriers from healthcare delivery and bring integrated care to people where they are, at a population scale.
Since our beginning, we’ve been committed to action in the face of critical healthcare problems.
Color Health launches with the mindset that healthcare should be affordable, accessible, and actionable.
In 2015, Color entered the genetics and cancer risk space with a clinical-grade genetic test for BRCA1, BRCA2, and 17 other key genes. At the time, genetic tests for ovarian and breast cancer risk could cost several thousand dollars. Color was the first to deliver comprehensive genetic testing at a population-scale for less than a tenth of the cost—or even at no cost through employer-provided benefits—arming hundreds of thousands of individuals with the knowledge of their unique cancer and cardiometabolic risk. Importantly, our support continued beyond testing. Color’s genetic counseling team worked with participants to help them understand their results and plan for action.
Learn how Color worked with the Teamsters Health and Welfare Fund of Philadelphia and Vicinity to increase employee engagement in their benefits and identify those at higher risk for cancer and other diseases.
Color begins a long history of partnering with leaders in research and precision medicine, starting with the National Institutes of Health.
In 2018, the National Institutes of Health (NIH) awarded funding to Color, in partnership with the Broad Institute of MIT and Harvard, to establish one of three genome centers for its historic All of Us Research Program. Color was recruited to analyze and report genomic data for a set of 59 genes that cause conditions such as breast and ovarian cancer, hypercholesterolemia, Lynch syndrome, and more. Color would also become the sole genetic counseling resource for participants.
Color continues its partnership with the NIH to this day, having gathered data from nearly 800,000 participants, many of whom represent populations who have been historically underrepresented in clinical research. Our work with the NIH was the first of many government partnerships to follow.
Color transforms access to critical COVID-19 testing, vaccination, and treatment services.
On March 16th, 2020, the first stay-at-home orders were issued in the Bay Area. Exactly two weeks later, Color had built a CLIA-certified COVID-19 testing lab and digital platform and announced its availability for public use. One week after that, Color published research-driven return-to-work protocols for employers.
In the months and years to come, Color partnered with employers, schools, and health departments across the country—Salesforce, the CDC, the Commonwealth of Massachusetts, Chicago Public Schools, to name a few—to deliver critical care where people worked, played, learned, and worshiped. When antiviral treatment became available, Color became one of the first providers of prescription delivery within 24 to 48 hours of symptom onset. To date, Color has tested, vaccinated, and treated millions. Learn about one of our community partnerships below.
Color partners with the American Cancer Society to operationalize a joint mission of ending cancer as we know it.
In June 2023, Color and the American Cancer Society (ACS) introduced a comprehensive cancer screening and prevention program for employers, combining the ACS’s expertise in clinical, evidence-based research on cancer prevention and Color’s leadership in population-scale healthcare delivery.
Rates of cancer screening, stage of detection, and treatment outcomes reflect some of the deepest disparities in American healthcare. With 159 million Americans receiving benefits through their employer, the ACS and Color recognize the critical role employers play in removing barriers of access to timely and quality preventive care. Hear from Hasbro employee and cancer survivor, Gina, on the importance of early detection and employer support.
Color and the American Cancer Society offer the first and only comprehensive cancer care solution for employers and unions.
Today, Color and the American Cancer Society have expanded our partnership to address the full continuum of cancer care, focusing on two key areas that have the biggest impact in the fight against cancer: 1) detecting cancer earlier, and 2) managing cancer more effectively. To meet these needs, Color built out an experienced clinical team through Color Medical to provide program participants with specialized, high-risk care, holistic support throughout treatment, and clinical and mental health support during survivorship.
After nearly a decade of working alongside healthcare and workplace innovators, breaking down barriers of access to essential health services, and providing exceptional patient experiences, we look forward to what the future holds.
If you’d like to learn more about the Color patient experience, read the results of our research study below.
Color Health launches with the mindset that healthcare should be affordable, accessible, and actionable.
In 2015, Color entered the genetics and cancer risk space with a clinical-grade genetic test for BRCA1, BRCA2, and 17 other key genes. At the time, genetic tests for ovarian and breast cancer risk could cost several thousand dollars. Color was the first to deliver comprehensive genetic testing at a population-scale for less than a tenth of the cost—or even at no cost through employer-provided benefits—arming hundreds of thousands of individuals with the knowledge of their unique cancer and cardiometabolic risk. Importantly, our support continued beyond testing. Color’s genetic counseling team worked with participants to help them understand their results and plan for action.
Learn how Color worked with the Teamsters Health and Welfare Fund of Philadelphia and Vicinity to increase employee engagement in their benefits and identify those at higher risk for cancer and other diseases.
Color begins a long history of partnering with leaders in research and precision medicine, starting with the National Institutes of Health.
In 2018, the National Institutes of Health (NIH) awarded funding to Color, in partnership with the Broad Institute of MIT and Harvard, to establish one of three genome centers for its historic All of Us Research Program. Color was recruited to analyze and report genomic data for a set of 59 genes that cause conditions such as breast and ovarian cancer, hypercholesterolemia, Lynch syndrome, and more. Color would also become the sole genetic counseling resource for participants.
Color continues its partnership with the NIH to this day, having gathered data from nearly 800,000 participants, many of whom represent populations who have been historically underrepresented in clinical research. Our work with the NIH was the first of many government partnerships to follow.
Color transforms access to critical COVID-19 testing, vaccination, and treatment services.
On March 16th, 2020, the first stay-at-home orders were issued in the Bay Area. Exactly two weeks later, Color had built a CLIA-certified COVID-19 testing lab and digital platform and announced its availability for public use. One week after that, Color published research-driven return-to-work protocols for employers.
In the months and years to come, Color partnered with employers, schools, and health departments across the country—Salesforce, the CDC, the Commonwealth of Massachusetts, Chicago Public Schools, to name a few—to deliver critical care where people worked, played, learned, and worshiped. When antiviral treatment became available, Color became one of the first providers of prescription delivery within 24 to 48 hours of symptom onset. To date, Color has tested, vaccinated, and treated millions. Learn about one of our community partnerships below.
Color partners with the American Cancer Society to operationalize a joint mission of ending cancer as we know it.
In June 2023, Color and the American Cancer Society (ACS) introduced a comprehensive cancer screening and prevention program for employers, combining the ACS’s expertise in clinical, evidence-based research on cancer prevention and Color’s leadership in population-scale healthcare delivery.
Rates of cancer screening, stage of detection, and treatment outcomes reflect some of the deepest disparities in American healthcare. With 159 million Americans receiving benefits through their employer, the ACS and Color recognize the critical role employers play in removing barriers of access to timely and quality preventive care. Hear from Hasbro employee and cancer survivor, Gina, on the importance of early detection and employer support.
Color and the American Cancer Society offer the first and only comprehensive cancer care solution for employers and unions.
Today, Color and the American Cancer Society have expanded our partnership to address the full continuum of cancer care, focusing on two key areas that have the biggest impact in the fight against cancer: 1) detecting cancer earlier, and 2) managing cancer more effectively. To meet these needs, Color built out an experienced clinical team through Color Medical to provide program participants with specialized, high-risk care, holistic support throughout treatment, and clinical and mental health support during survivorship.
After nearly a decade of working alongside healthcare and workplace innovators, breaking down barriers of access to essential health services, and providing exceptional patient experiences, we look forward to what the future holds.
If you’d like to learn more about the Color patient experience, read the results of our research study below.
Our population-scale impact
>7M
patients served
>26M
healthcare interventions delivered
>13K
healthcare access sites
>2K
organizations supported
Our partnership with the American Cancer Society
In partnership with the American Cancer Society, we’re delivering comprehensive, quality cancer care and high-touch patient support where and when people need it most. From preventive education and early detection to integrated care before, during, and after a diagnosis, we’re helping organizations and individuals take control of cancer.
Our partnership with the American Cancer Society
In partnership with the American Cancer Society, we’re delivering comprehensive, quality cancer care and high-touch patient support where and when people need it most. From preventive education and early detection to integrated care before, during, and after a diagnosis, we’re helping organizations and individuals take control of cancer.
“The biggest impact happens when we meet patients and their families where they live, work, and play. Comprehensive support for cancer can start in the workplace. At the American Cancer Society, we’re proud to work with Color to help employers take action.”
Designed for people. Built for populations.
Color’s ultimate goal is to empower individuals to take action on their health. To do so, we focus on removing the logistical, technological, financial, and cultural barriers that accompany traditional healthcare delivery.
With nearly a decade of experience in the cancer and genetic risk space, Color has served millions and partnered with innovators such as the National Institutes of Health, the International Brotherhood of Teamsters, and Salesforce.
Our approach is both targeted and scalable—built with infrastructure that meets the needs of large organizations, while remaining designed for accessible, patient-centered care.
We’re proud to partner with leaders in every industry.
Let’s work together to take control of cancer.
Are you passionate about changing healthcare for the better? Do you love digging in to solve tough problems? If so, we want to work with you.
Our licensing and accreditation
Color has an advanced, CAP-accredited and CLIA-certified laboratory that uses the newest technology, such as acoustic liquid handlers and autonomous, self-optimizing robotic systems, to ensure the integrity of every sample.
Color’s licenses and certifications include:
CAP
8975161
CLIA
05D2081492
California
CLF 00346276
Maryland
2376
New York
PFI 9069
Pennsylvania
034727
Rhode Island
LCO01577
Speak with an expert.
Want to get in touch with our team? We’re just a click away.
New to Color?
Whether you want to learn more about Color or you’re ready to start your journey with us, you’re in the right place.
Already a customer?
If you need help with your account, sample submission, or other service-related issue, we’re here.
New to Color?
Whether you want to learn more about Color or you’re ready to start your journey with us, you’re in the right place.
Already a customer? Get support.
Call us toll-free between 6am and 5pm PT at (844) 352-6567. Those outside the US can reach us at +1 650-651-7116. We’re also available via email at support@color.com.
For frequently asked questions please visit support.color.com.
